Publicacións en colaboración con investigadores/as de University of Manchester (8)

2015

  1. A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility

    American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580

2011

  1. Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2010

  1. Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2009

  1. Regulated upon activation normal T-cell expressed and secreted (RANTES) and epithelial cell-derived neutrophil-activating peptide (ENA-78) gene polymorphisms in patients with biopsy-proven erythema nodosum

    Clinical and Experimental Rheumatology

2008

  1. Interleukin-6 promoter polymorphism at position - 174 in biopsy-proven patients with erythema nodosum from a defined population

    Clinical and Experimental Rheumatology

2007

  1. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis

    Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132

  2. Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura

    Clinical and Experimental Rheumatology, Vol. 25, Núm. 1 SUPPL. 44

2006

  1. Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis

    Clinical and Experimental Rheumatology, Vol. 24, Núm. 5, pp. 576-579